Intrinsic Value
Crinetics Pharmaceuticals, Inc. (CRNX)
$43.99
+0.98 (+2.28%)
| Enterprise Value | -46,633,199.68 |
|---|---|
| Net Debt | -3.17 |
| Equity Value | -46,633,196.51 |
| Shares Outstanding | 58.07 |
| Equity Value Per Share | -803,037.60 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt